NCT02963337View on ClinicalTrials.gov

Remifentanil vs. Combined Spinal-epidural Analgesia for Labor Analgesia and Progress of Labor in Multiparous

CompletedOBSERVATIONAL

Enrollment

162

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

September 1, 2018

Study Completion Date

September 1, 2018

Conditions

Labor PainLabor; Prolonged, Second StageLabor; Prolonged, First Stage

Interventions

DRUG

remifentanil

Remifentanil PCA will be used to deliver intravenous drug boluses from 20 to 40 micrograms per 2 min lockout interval.

DRUG

combined spinal-epidural analgesia

Patient controlled epidural analgesia will be used to deliver epidural boluses of 6-10 ml of 0,1% bupivacaine with 2 micrograms of fentanyl per ml per 15 min lockout interval.

Trial Locations (1)

1000

University Medical Centre Ljubljana, Ljubljana, Slovenia, Ljubljana

All Listed Sponsors

lead

University Medical Centre Ljubljana

OTHER

NCT02963337 - Remifentanil vs. Combined Spinal-epidural Analgesia for Labor Analgesia and Progress of Labor in Multiparous | Biotech Hunter | Biotech Hunter